Edward Carr insider trades
Open-market stock purchases and sales by Edward Carr, CHIEF ACCOUNTING OFFICER at Dianthus Therapeutics, Inc /DE/, from SEC Form 4 filings since Nov 19, 2018.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Sep 17, 2026 | DNTH Dianthus Therapeutics, Inc /DE/ | Sold | $796K |
| Sep 17, 2026 | DNTH Dianthus Therapeutics, Inc /DE/ | Sold | $686K |
| Sep 17, 2026 | DNTH Dianthus Therapeutics, Inc /DE/ | Sold | $358K |
| Sep 17, 2026 | DNTH Dianthus Therapeutics, Inc /DE/ | Sold | $114K |
| Sep 17, 2026 | DNTH Dianthus Therapeutics, Inc /DE/ | Sold | $73.1K |
| Sep 17, 2026 | DNTH Dianthus Therapeutics, Inc /DE/ | Bought (not open market) | — |
| Mar 12, 2026 | DNTH Dianthus Therapeutics, Inc /DE/ | Bought (not open market) | — |
| Mar 12, 2026 | DNTH Dianthus Therapeutics, Inc /DE/ | Sold | $1.3M |
| Mar 12, 2026 | DNTH Dianthus Therapeutics, Inc /DE/ | Sold | $1.9M |
| Mar 12, 2026 | DNTH Dianthus Therapeutics, Inc /DE/ | Sold | $319K |
| Mar 12, 2026 | DNTH Dianthus Therapeutics, Inc /DE/ | Sold | $16.7K |
| Mar 12, 2026 | DNTH Dianthus Therapeutics, Inc /DE/ | Sold | $25.7K |
| Mar 12, 2026 | DNTH Dianthus Therapeutics, Inc /DE/ | Bought (not open market) | — |
| Mar 12, 2026 | DNTH Dianthus Therapeutics, Inc /DE/ | Bought (not open market) | — |
| Feb 3, 2026 | DNTH Dianthus Therapeutics, Inc /DE/ | Bought (not open market) | — |